XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Net Sales $ 19,122 $ 15,927 $ 54,238 $ 50,912
Cost of Sales 16,011 13,655 44,987 43,095
Gross Profit 3,111 2,272 9,251 7,817
Research and Product Development 114 0 154 0
Selling and Marketing 572 531 1,716 1,814
General and Administrative 3,799 3,325 11,296 10,296
Transaction-related expenses 847 0 847 0
Operating Loss (2,221) (1,584) (4,762) (4,293)
Other Income (Expense):        
Realized Gain on Available-for-Sale Investments 128 61 378 181
Interest Expense (282) (285) (845) (838)
Interest Income 51 55 128 190
Total Other Expense, net (103) (169) (339) (467)
Net Loss $ (2,324) $ (1,753) $ (5,101) $ (4,760)
Basic Net (Loss) Income per Share (in dollars per share) $ (0.59) $ (0.49) $ (1.33) $ (1.41)
Diluted Net (Loss) Income per Share (in dollars per share)     $ (1.33) $ (1.41)
Basic Weighted Average Shares Outstanding (in shares) 3,971,984 3,602,494 3,957,624 3,481,797
Diluted Weighted Average Shares Outstanding (in shares) 3,971,984 3,602,494 3,957,624 3,481,797